News

National campaign seeks to empower everyone to stop bleeding & save lives

Stop the Bleed seeks to empower every citizen with the knowledge and tools to stop life-threatening bleeding and save lives. The top cause of preventable death in trauma is bleeding. 20% of people who have died from traumatic injuries could have survived with quick bleeding control. Stop the Bleed is a national awareness campaign and a call to action. Laun.....
[...]

HemCon Nasal Plug effective and affordable treatment for uncontrolled anterior epistaxis

In a case study of 33 patients, HemCon Nasal Plug was found to be an effective adjunct in the prehospital treatment of uncontrolled anterior epistaxis. HemCon Nasal Plug effectively stops anterior nose bleeding, even when other products fail to stop the bleeding; are well-tolerated by patients due to the small size, compared to other nasal tampons; are .....
[...]

Hemostatic Agents Illustrate Cost Savings, OR Today

GuardaCareXR Surgical contributes to OR cost savings by controlling bleeding reliably, saving procedural times and reducing blood loss, which ultimately improves patient safety and outcomes. Severe or excessive patient bleeding is one of the most common problems or complications experienced by OR personnel during surgery. It’.....
[...]

Tricol Completes Asset Acquisition of HemCon

Tricol International Group Limited Completes Asset Acquisition of HemCon Medical Technologies Inc. Global microfiber expert to stabilize and focus growth of Oregon based advanced wound care company. Tricol International Group Ltd., a Marshall Islands based company and global leader in microfiber products along with its 100% wholly owned Oregon based subsidiary Tricol Biomedical, Inc. announced today that it has acquired HemCon Medical Technologies Inc. E.....
[...]

Prehospital use of hemostatic dressings in emergency medical services in the Netherlands: A prospective study of 66 cases

Grotenhuis, R., et al. Injury, Int. J. Care Injured 47 (2016) 1007–1011. Over 2.5 years all ambulances [...]

HemCon & OHSU are Awarded Additional NIH Grant

Collaboration Between HemCon and OHSU is Awarded Additional NIH Grant with Total Value of $1.1M for the Development of a Transurethral Hemostatic Device Portland, OR., May 6, 2015 – HemCon Medical Technologies, Inc. (HemCon) has been awarded funding from the National Institutes of Health (NIH) to develop a novel chitosan endoluminal hemostatic dressing that is able to be delivered by a catheter to control and prevent prostatic bleeding during prostatic surgery su.....
[...]

Strategic Facility Relocation

HemCon has moved its office headquarters to downtown Portland into an innovative human centered work environment designed to foster greater connectivity between all employees, customers and stakeholders. HemCon also transitioned its manufacturing to an outsourced model in the U.S. Full press release below HemCon Announces Strategic Facility Relocation to Support Rapid Growth and New Product Development Implementation of a strategic plan to create a promine.....
[...]

ChitoGauze now Recommended by COTCCC

U.S. Department of Defense’s Committee on Tactical Combat Casualty Care (CoTCCC) updated its guideline recommendations to include HemCon’s ChitoGauze hemostatic chitosan-coated gauze product. “The official acknowledgment of ChitoGauze’s efficacy given by the addition to the CoTCCC guidelines is a true testament to HemCon’s dedication to always provide products that can help save lives,” said Michael Wax, CEO and President .....
[...]

Massive bleeding: The prehospital use of HemCon hemostatic bandages

Four Dutch helicopter emergency medical teams (HEMS) used HemCon® ChitoGauze® in the field to control traumatic bleeding and recorded successful results after a minimal application time of five minutes. Four helicopter emergency medical teams (HEMS) are available to support ambulances in Dutch setting. Nijmegen HEMS uses HemCon hemostatic bandages since 2009. Between April 2009 and J.....
[...]